Welcome to the Investor Centre

Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

Our main goals are to make a difference to patients' lives and generate a superior return for our investors.

Highlights

£239m

NAV (at 30 June 2023)

185p

NAV per share (at 30 June 2023)

£101m

Cash (at 30 June 2023)

£134.4m

GPV (at 30 June 2023)

LON:ARIX